Recombinant Human CEACAM1 (C-6His)

Description

EnkiLife provides the Recombinant Human CEACAM1 (C-6His) protein,aslo know as Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1,Biliary Glycoprotein 1,BGP-1,CD66a,CEACAM1,BGP,BGP1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 is produced by our Mammalian expression system and the target gene encoding Gln35-Gly428 is expressed with a 6His tag at the C-terminus.Accession:P13688. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:44.33 KDa. Background:Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) is a member of the Carcinoembryonic Antigen (CEA) family, which belongs to the immunoglobulin superfamily. CEACAM1 is originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it is found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. CEACAM1 mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. In addition, CEACAM1 plays a important role in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses.